Albany New York November 28 2016: A recent report has been launched by Global Market Direct’s pharmaceutical and healthcare disease pipeline guide which has been broadcasted to the massive database of Market Research Hub (MRH). The research study of
680 pages titled as “Acute Lymphocytic Leukemia (ALL Acute Lymphoblastic Leukemia)- Pipeline Review H2 2016” provides broad information on the therapeutics under development for Acute Lymphocytic Leukemia (Oncology) with the complete analysis by stage
of development drug target route of administration (RoA) mechanism of action (MoA) and molecule type. The guide is assembled using data and information sourced from Global Markets Direct’s proprietary databases company/university websites clinical trial archives conferences SEC filings investor presentations featured news & press releases and industry-specific third party sources.